1 From the Department of Medicine and The Harold Brunn Institute for Cardiovascular Research, Mount Zion Hospital, San Francisco, Calif.
Quinidine sulfate, orally administered in tablets coated with a material delaying their absorption, produces concentration curves in the blood serum similar to those of uncoated tablets. However, there is a delay in the appearance and the attaining of maximum concentrations with the coated tablets, although higher levels may persist for 12 hours. Defects in coating may cause faulty failure of absorption. The advantages of using such a preparation of quinidine are: (1) avoidance of nausea in susceptible persons, (2) providing effective concentrations of the drug during the night and thereby preventing nocturnal attacks of arrhythmias, and (3) providing greater concentrations of the drug in the morning, when attempts at conversions of arrhythmias may require therapy over several days or more.
© 1952 American Heart Association, Inc.
Studies of Plasma Quinidine Content
III. The Value of Delayed Absorptive Coated Tablets in Oral Quinidine Therapy
This article has been cited by other articles:
![]() |
N. Shaftel and A. Halpern The Quinidine Problem Angiology, February 1, 1958; 9(1): 34 - 46. [PDF] |
||||
![]() |
S. BELLET, D. FINKELSTEIN, and H. GILMORE Study of a Long-Acting Quinidine Preparation: Experience in Normal Subjects and in Patients with Myocardial Abnormality Arch Intern Med, November 1, 1957; 100(5): 750 - 758. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1952 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |